Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

Eva J. Razumienko; Deborah A. Scollard; Raymond M. Reilly

doi:10.2967/jnumed.112.106906

Research ArticleBasic Science Investigations

Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

Eva J. Razumienko, Deborah A. Scollard and Raymond M. Reilly

Journal of Nuclear Medicine December 2012, 53 (12) 1943-1950; DOI: https://doi.org/10.2967/jnumed.112.106906

Eva J. Razumienko

1Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Deborah A. Scollard

1Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Raymond M. Reilly

1Department of Pharmaceutical Sciences, University of Toronto, Toronto, Ontario, Canada

2Department of Medical Imaging, University of Toronto, Toronto, Ontario, Canada; and

3Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Supplemental
Info & Metrics
PDF

Data supplements

Supplemental Data

Files in this Data Supplement:

Supplemental Data

PreviousNext

In this issue

Journal of Nuclear Medicine

Vol. 53, Issue 12

December 1, 2012

Table of Contents
Table of Contents (PDF)
About the Cover
Index by author

Download PDF

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

Eva J. Razumienko, Deborah A. Scollard, Raymond M. Reilly

Journal of Nuclear Medicine Dec 2012, 53 (12) 1943-1950; DOI: 10.2967/jnumed.112.106906

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

Eva J. Razumienko, Deborah A. Scollard, Raymond M. Reilly

Journal of Nuclear Medicine Dec 2012, 53 (12) 1943-1950; DOI: 10.2967/jnumed.112.106906

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Supplemental
Info & Metrics
PDF

This Month in JNM

PubMed
Google Scholar

Cited By...

Immuno-PET to Optimize the Dose of Monoclonal Antibodies for Cancer Therapy: How Much Is Enough?
Dual-Targeted Molecular Imaging of Cancer
Dual-Receptor-Targeted Radioimmunotherapy of Human Breast Cancer Xenografts in Athymic Mice Coexpressing HER2 and EGFR Using 177Lu- or 111In-Labeled Bispecific Radioimmunoconjugates

Google Scholar

Keywords

breast cancer
SPECT
111In
HER2
HER3

Main menu

User menu

Search

Small-Animal SPECT/CT of HER2 and HER3 Expression in Tumor Xenografts in Athymic Mice Using Trastuzumab Fab–Heregulin Bispecific Radioimmunoconjugates

Data supplements

Supplemental Data

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Similar Articles

Keywords